Hyperfine Inc. (HYPR)
NASDAQ:HYPR
Want to see HYPR full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.09Last Year’s EPS
-0.12Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlights strong commercial traction for the next-generation subsystem with 83% YoY revenue growth, significant gross margin expansion (~940 bps), improving cash burn, important regulatory and clinical milestones (CE/UKCA, Optive AI launch, >50% enrollment in contrast PMR), and reiterated conservative yet growth-oriented FY2026 guidance. Offsetting these positives are continued net losses, meaningful full‑year cash burn requirements, reliance on a debt facility for liquidity, longer sales cycles for IDNs that can delay larger deals, and the fact that contrast indication and broader international scale are still pending. Overall, the progress, momentum, and margin improvement dominate the risks in the near term.Company Guidance
Strong Revenue Growth
Q1 revenue of $3.9M, up 83% year-over-year from $2.1M; sold 10 units versus 6 in the prior-year period, driven largely by next-generation subsystem sales across hospitals, neurology offices and international.
Meaningful Gross Margin Expansion
Gross profit of $2.0M and gross margin of 50.7% versus 41.3% in prior year — ~940 basis points (9.4 percentage points) expansion; third consecutive quarter with gross margin >50% and guidance reiterating 50%–55% for FY2026.
Improved Cash Burn and Liquidity
Net cash burn excluding financing improved to $8.8M from $10.1M (≈13% improvement). Cash and equivalents of $40.8M as of 03/31/2026 (includes $15M initial tranche of up to $40M debt facility). Company expects cash runway into 2028 (inclusive of initial tranche).
Cost Discipline and Operating Leverage
R&D expense reduced ~24% to $3.8M (from $5.0M) as company transitions to a commercial growth-stage operating model; SG&A held flat at $6.7M versus prior year, demonstrating spending discipline while scaling sales productivity.
Regulatory and Clinical Milestones
Received CE and UKCA marks for next-generation subsystem and advanced Optive AI software; advanced DWI Optive AI launched at International Stroke Conference; Neuro‑PMR and other study data presented at major meetings showing high diagnostic value and strong patient preference.
Progress on Contrast PMR and International Expansion
Contrast PMR study enrollment surpassed 50% of target with 3 active sites; company expects potential submission in 2026 to expand indication for gadolinium contrast. First two systems live in India; Optive AI launched in Europe and plans to launch next-gen subsystem in Europe in Q3 after translations/documentation.
Reiterated 2026 Guidance with Upside Potential
Reiterated full‑year revenue guidance of $20M–$22M (midpoint ≈55% YoY growth), gross margin guidance 50%–55%, and total cash burn guidance of $26M–$28M (midpoint ≈10% YoY decline). Company expects revenue to strengthen in second half of 2026.
HYPR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HYPR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2026 | $1.73 | $1.59 | -8.09% |
Mar 18, 2026 | $1.27 | $1.21 | -4.72% |
Nov 13, 2025 | $1.05 | $1.15 | +9.52% |
Aug 13, 2025 | $1.27 | $1.45 | +14.17% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Hyperfine Inc. (HYPR) report earnings?
Hyperfine Inc. (HYPR) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Hyperfine Inc. (HYPR) earnings time?
Hyperfine Inc. (HYPR) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HYPR EPS forecast?
HYPR EPS forecast for the fiscal quarter 2026 (Q2) is -0.09.